                         SEQUENCE LISTING

<110>  Macfarlane Burnet Institute for Medical Research and Public
        Health Limited
       Chancellor, Masters and Scholars of the University of 
       Oxford
 
<120>  Compositions and their prophylactic or therapeutic use

<130>  528825PCT

<150>  AU 2020901506
<151>  2020-05-11

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  248
<212>  PRT
<213>  Hepatitis C virus

<400>  1

Gly Thr Ala Ser Ala Thr Met Asn Pro Leu Leu Ile Leu Thr Phe Val 
1               5                   10                  15      


Ala Ala Ala Leu Ala Glu Thr His Gln Asn Ile Gln Leu Ile Asn Thr 
            20                  25                  30          


Asn Gly Ser Trp His Ile Asn Ser Thr Ala Leu Asn Cys Asn Glu Ser 
        35                  40                  45              


Leu Asn Thr Gly Trp Leu Ala Gly Leu Phe Tyr Gln His Lys Phe Asn 
    50                  55                  60                  


Ser Ser Gly Cys Pro Glu Arg Leu Ala Ser Cys Gly Ser Ser Gly Cys 
65                  70                  75                  80  


Trp His Tyr Pro Pro Arg Pro Cys Gly Ile Val Pro Ala Lys Ser Val 
                85                  90                  95      


Cys Gly Pro Val Tyr Cys Phe Thr Pro Ser Pro Val Val Val Gly Thr 
            100                 105                 110         


Thr Asp Arg Ser Gly Ala Pro Thr Tyr Ser Trp Gly Ala Asn Asp Thr 
        115                 120                 125             


Asp Val Phe Val Leu Asn Asn Thr Arg Pro Pro Leu Gly Asn Trp Phe 
    130                 135                 140                 


Gly Cys Thr Trp Met Asn Ser Thr Gly Phe Thr Lys Val Cys Gly Ala 
145                 150                 155                 160 


Pro Pro Cys Gly Ser Ser Gly Cys Pro Thr Asp Cys Phe Arg Lys His 
                165                 170                 175     


Pro Glu Ala Thr Tyr Ser Arg Cys Gly Ser Gly Pro Trp Ile Thr Pro 
            180                 185                 190         


Arg Cys Met Val Asp Tyr Pro Tyr Arg Leu Trp His Tyr Pro Cys Thr 
        195                 200                 205             


Ile Asn Tyr Thr Ile Phe Lys Val Arg Met Tyr Val Gly Gly Val Glu 
    210                 215                 220                 


His Arg Leu Glu Ala Ala Cys Asn Trp Thr Arg Gly Glu Arg Cys Asp 
225                 230                 235                 240 


Leu Glu Asp Arg Asp Arg Ser Glu 
                245             


<210>  2
<211>  744
<212>  DNA
<213>  Hepatitis C virus

<400>  2
ggtaccgcta gcgccaccat gaaccccctg ctgatcctga ccttcgtggc tgcagccctg       60

gccgagaccc accagaacat ccagctgatc aacaccaacg gcagctggca catcaacagc      120

accgccctga actgcaacga gagcctgaac accggctggc tggccggcct gttctaccag      180

cacaagttca acagcagcgg ctgccccgag aggctcgcct cctgcggcag cagcggctgc      240

tggcactacc cccccagacc ctgcggcatc gtgcccgcca agagcgtgtg cggccctgtg      300

tactgcttca cccccagccc cgtggtggtg ggcaccaccg acagaagcgg agcccccacc      360

tacagctggg gcgccaacga caccgacgtg ttcgtgctga acaacaccag accccccctg      420

ggcaactggt tcggctgcac ctggatgaac agcaccggct tcaccaaagt gtgtggcgcc      480

cctccctgcg gcagcagcgg ctgccccacc gactgcttta ggaaacaccc cgaggccacc      540

tactccagat gcggcagcgg cccctggatc accccccggt gcatggtgga ctacccctac      600

cggctgtggc actatccctg caccatcaac tacaccatct tcaaagtgcg gatgtacgtg      660

ggaggcgtcg agcataggct ggaagcagct tgcaattgga caaggggcga gcggtgcgac      720

ctggaagatc gggaccgcag cgag                                             744


